menu search

JNJ / Johnson & Johnson Just Cut an Entire Division. Is It Still a Buy?

Johnson & Johnson Just Cut an Entire Division. Is It Still a Buy?
Johnson & Johnson is cutting its drug development efforts for infectious diseases. It hasn't said anything about ceasing sales of its products on the market. Read More
Posted: Aug 31 2023, 06:12
Author Name: The Motley Fool
Views: 103185

JNJ News  

Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know

By Zacks Investment Research
November 3, 2023

Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know

Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can imp more_horizontal

J&J stock down as business unit mulls talc-related bankruptcy

By MarketBeat
October 31, 2023

J&J stock down as business unit mulls talc-related bankruptcy

Shares of Johnson & Johnson NYSE: JNJ slid 4.84% lower the week ending October 27, as the company's subsidiary LTL Management is facing a raft of laws more_horizontal

Have $500? 2 Absurdly Cheap Stocks Long-Term Investors Should Buy Right Now

By The Motley Fool
October 28, 2023

Have $500? 2 Absurdly Cheap Stocks Long-Term Investors Should Buy Right Now

These two market leaders offer you solid earnings prospects and the promise of dividend growth. They both look cheap today, considering their track re more_horizontal

Johnson & Johnson produces documents in DoJ civil investigation of eye products

By Reuters
October 27, 2023

Johnson & Johnson produces documents in DoJ civil investigation of eye products

Johnson & Johnson has begun providing documents and information in response to a civil investigation by the U.S. Department of Justice related to free more_horizontal

Should You Pick Johnson & Johnson Stock After A 6% Fall In A Month Despite Upbeat Q3?

By Forbes
October 25, 2023

Should You Pick Johnson & Johnson Stock After A 6% Fall In A Month Despite Upbeat Q3?

Johnson & Johnson (NYSE: JNJ) reported its Q3 results last week, with revenues and earnings beating the street estimates. more_horizontal

Down in the Double Digits, These 2 Classic Warren Buffett Stocks Make Great Buys Now

By The Motley Fool
October 22, 2023

Down in the Double Digits, These 2 Classic Warren Buffett Stocks Make Great Buys Now

The Oracle of Omaha favors solid companies that are undervalued -- and he holds on for the long term. Buffett often invests in companies selling goods more_horizontal

2 Attractive High Dividend Yield Buys For Your Dividend Income Portfolio

By Seeking Alpha
October 21, 2023

2 Attractive High Dividend Yield Buys For Your Dividend Income Portfolio

This week, two additional companies have been added to The Dividend Income Accelerator Portfolio. Both companies pay an attractive Dividend Yield, hav more_horizontal

2 Warren Buffett Dividend Stocks to Buy and Hold Forever

By The Motley Fool
October 21, 2023

2 Warren Buffett Dividend Stocks to Buy and Hold Forever

Johnson & Johnson has a stable business and one of the most impressive dividend streaks. Visa is one of the two undisputed leaders in an industry that more_horizontal


Search within

Pages Search Results: